Lab Automation In Drug Discovery Market Report 2026

Lab Automation In Drug Discovery Market Overview

• Lab Automation In Drug Discovery market size has reached to $6.77 billion in 2025 • Expected to grow to $8.72 billion in 2030 at a compound annual growth rate (CAGR) of 5.2% • Growth Driver: Rising Demand For Precision Medicine Propels The Growth Of Lab Automation In Drug Discovery Market • Market Trend: AI-Enabled Robotics Accelerating Formulation Development And Transforming Drug Discovery Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lab Automation In Drug Discovery Market?

Lab automation in drug discovery refers to the use of advanced technologies and robotics to streamline and optimize laboratory processes related to new drug development and research. It is used to significantly enhance the speed and success rate of drug discovery efforts by automating repetitive tasks and integrating advanced instruments and software. The main types of lab automation in drug discovery are automated liquid handlers, automated plate handlers, robotic arms, automated storage and retrieval systems, and others. Automated liquid handlers are machines designed to dispense and handle liquids automatically, and they are often used in laboratories for precise and efficient liquid handling tasks such as pipetting and dilution. The various components include instruments, software, and services, which are used in several applications, such as high-throughput screening, compound management, sample preparation, and others. These are used by various end-users, including biotechnology and pharmaceutical industries, research institutes, and others.

What Is The Lab Automation In Drug Discovery Market Growth Forecast?

The lab automation in drug discovery market size is expected to see strong growth in the next few years. It will grow to $8.72 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to expansion of ai-driven drug discovery platforms, increasing demand for personalized medicine, growth in cloud-based lab management solutions, adoption of advanced robotics for sample handling, rising collaborations between pharma and biotech companies. Major trends in the forecast period include high-throughput screening automation, integrated laboratory workflows, predictive analytics in drug discovery, miniaturization of lab processes, cloud-based lab management.

Global Lab Automation In Drug Discovery Market Segmentation

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types 2) By Component: Instruments, Software, Services 3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications 4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users Subsegments: 1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations 2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems 3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots 4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems 5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

What Is The Driver Of The Lab Automation In Drug Discovery Market?

The increasing demand for precision medicine is expected to propel the growth of lab automation in the drug discovery market going forward. Precision medicine, also known as personalized medicine, is an approach to medical treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. Lab automation accelerates research, improves experimental repeatability, and improves the efficiency of precision medicine and drug discovery procedures, ultimately leading to the creation of more effective medicines and diagnostics suited to individual patients. For instance, in February 2024, Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, a significant increase from the six approved in 2022. Therefore, the increasing demand for precision medicine is driving the growth of lab automation in the drug discovery market.

Key Players In The Global Lab Automation In Drug Discovery Market

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Synchron Lab Automation

Global Lab Automation In Drug Discovery Market Trends and Insights

Major companies operating in lab automation in the drug discovery market are focusing on integrating AI-driven and robotics-based platforms to accelerate formulation development and enhance R&D efficiency. AI-powered and robot-assisted platforms use smart algorithms and automated machines to streamline tasks, boost precision, and speed up workflows. For instance, in May 2025, Intrepid Labs, a Canada-based research laboratory, has launched its Valiant platform, an AI-driven and robotics-enabled system designed to dramatically accelerate drug formulation development. Supported by more than $11 million in total funding including a recent $7 million seed round led by AVANT BIO the company aims to replace slow, trial-and-error formulation processes with rapid, data-driven optimization. Valiant explores full formulation design spaces autonomously, reducing timelines from months to days while improving therapeutic performance and safety. Since its 2023 founding, Intrepid Labs has secured partnerships with major pharmaceutical companies and CROs, and is also developing proprietary oral and long-acting injectable technologies for licensing.

What Are Latest Mergers And Acquisitions In The Lab Automation In Drug Discovery Market?

In March 2023, Brooks Automation, a US-based automation solution company, acquired Aim Lab Automation Technologies Pty Ltd. for an undisclosed amount. With this acquisition, Brooks' lab automation aims to expand its market presence into clinical diagnostics and drive technological advancements, significantly impacting lab automation in the drug discovery market. Aim Lab Automation Technologies Pty Ltd. is an Australia-based company that provides robotic automation instrumentation and modules along with automation solutions designed to enhance automation processes in drug discovery labs.

Regional Insights

North America was the largest region in the lab automation in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Lab Automation In Drug Discovery Market?

The lab automation in drug discovery market consists of revenues earned by entities by providing services such as compound screening, assay development, high-throughput screening, data analysis, and optimization of drug candidates. The market value includes the value of related goods sold by the service provider or included within the service offering. The lab automation in drug discovery market also includes sales of robotics and automated workstations, screening systems, plate readers, and others. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Lab Automation In Drug Discovery Market Report 2026?

The lab automation in drug discovery market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lab automation in drug discovery industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.